Fluconazole Tablet
Product Images NDC 50268-339

9 FDA label images from Avpak · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Fluconazole (NDC 50268-339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fluconazole Str)

Chemical Structure (Fluconazole Str)
Chemical structure of fluconazole, showing its molecular arrangement with two triazole rings, a difluorophenyl group, and hydroxyl substituent as part of its composition.*
FDA Label Image

1 (Table 1)

1 (Table 1)
Data table titled 'Mean Pharmacokinetic Parameters of Fluconazole in Adult Healthy Volunteers Following the Administration of Fluconazole Tablets'. It lists dose regimens from 50 mg to 400 mg orally, with corresponding Cmax (mcg/mL), AUC0-24 (mcg*h/mL), and half-life (hours) parameters for each dose.*
FDA Label Image

3 (Table 3)

3 (Table 3)
A pharmacokinetic parameters table for Fluconazole in pediatric patients showing data on clearance, half-life, Cmax, AUC, and volume of distribution (Vdss) across different ages and doses. The table includes study groups from 2 days to 15 years with various oral and IV dosing regimens, presenting mean values with coefficient of variation percentages and sample sizes.*
FDA Label Image

4 (Table 4)

4 (Table 4)
A data table titled 'Table 4: Death or Candidiasis by Day 49 in Premature Infants Receiving Fluconazole Prophylaxis' comparing the incidence of death or candidiasis between groups receiving fluconazole and placebo. It presents counts and percentages for death or candidiasis, components of the endpoint (death, candidiasis, missing data), p-values, and difference with confidence intervals.*
FDA Label Image

5 (Table 5)

5 (Table 5)
A data table listing serious adverse reactions occurring in more than 5% of infants receiving Fluconazole prophylaxis compared to placebo. The table includes adverse reactions such as necrotizing enterocolitis, intestinal perforation, neonatal respiratory arrest, and bacterial sepsis, with respective percentages and counts for Fluconazole and placebo groups.*
FDA Label Image

1 (Table 6)

1 (Table 6)
A table titled 'Recommended Dosing Regimens for the Treatment of Systemic Candida Infections in Pediatric Patients' listing dosing regimens by patient age groups. It includes dosing for patients 3 months and older, birth to 3 months postnatal and gestational age 30 weeks and above, and birth to 3 months postnatal and gestational age less than 30 weeks.*
FDA Label Image

Directions: Push Tablet Through Foil And Take By Mouth (Fluconazole Fig1)

Directions: Push Tablet Through Foil And Take By Mouth (Fluconazole Fig1)
An instructional illustration showing a person holding a tablet near their mouth, demonstrating the action of pushing the tablet through the foil and placing it in the mouth. The accompanying text provides directions for taking the tablet by mouth.*
FDA Label Image

1 (337 15)

1 (337 15)
Packaging label for Fluconazole Tablets USP 100 mg oral tablets by AvPAK. The label shows a 50 tablet count (5 bottles of 10 tablets each) as unit dose. It includes the NDC number 50268-337-15, barcode, and storage instructions. The label notes Rx only and advises consulting package insert for dosage information.*
FDA Label Image

1 (339 15)

1 (339 15)
Fluconazole Tablets USP 200 mg oral tablets in a unit dose pack containing 50 tablets (5 x 10). The label shows the NDC 50268-339-15, manufacturer AvPAK, and includes storage instructions and a QR code. The label indicates prescription use only and provides directions to see the package insert for dosage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.